BTK and cancer: To this end, we synthesized previously reported BTK degraders DD-03-17132 and MT-80231 and compared them head-to-head with RC-1, RNC-1, and IRC-1 in their abilities to inhibit cancer cell growth (Fig. 2f and Supplementary Fig. 7).